MicrosensDx

MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

11 September 2024 -- Cambridge, UK -- MicrosensDx is excited to announce that it is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis. Based on MicrosensDx’s IP and technology, and designed to fit with existing diagnostic processes, this test could potentially fill...
204 Cambridge Science Park, Milton Road, Cambridge, CB4 0GZ

+44 (0)1223 626 252